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Vertebrate retinogenesis is a complex developmental process that requires the dynamic 
orchestration of multiple tissues and cell types, morphological changes, and intrinsic and 
extrinsic cellular signaling. Intertwined with these processes are coordinated genetic and 
epigenetic mechanisms that function to regulate cellular state, proliferation, differentiation, 
and maintenance of retinal progenitor cells and neurons. Disruption of the DNA methylome 
or micro-RNA pathways, the regulatory pathways examined in this study, results in 
aberrant cellular proliferation, differentiation, and retinal homeostasis. Additionally, 
defects in these pathways are known to result in tumorigenesis, embryonic lethality, and 
neurodegenerative disease. Data presented in this thesis address the role of maintenance 
and de novo DNA methylation in the retina. Utilizing the zebrafish as a model for vertebrate 
retinal stem cell (RSC) maintenance and development, I demonstrated a requirement for 
dnmt1, the maintenance DNA methyltransferase, in RSC maintenance through the 
regulation of cell cycle genes, cell survival, and dysregulation of retroviral elements (RE). 
Additionally, I generated combinatorial mutants for the six de novo DNA methylation 
genes using TALEN and CRISPR/Cas9 mutagenesis to assess the function of these 
enzymes during retinogenesis. The tested combinations of mutant alleles lack overt 
 vii 
phenotypes, however further analyses will be critical for determining their gene-specific 
and likely overlapping roles within the retina. Finally, I aimed to characterize the role of 
the dual-specificity phosphatase enzyme, Dusp11, within the retina. Utilizing a Dusp11, 
splice-mutant mouse line, I lay the groundwork for characterizing this enzyme in vivo and 
assessing its roles in retinal maintenance and potential contribution to retinal degeneration 
diseases. Through the use of Spectral Domain Optical Coherence Tomography (SD-OCT), 
I performed longitudinal experiments to assess retinal lamination and structure. 
Additionally, preliminary immunohistochemistry unveiled potential cell type-specific 
localization of Dusp11. These findings require further validation, but provide a first 
glimpse into ocular requirements for Dusp11 function and potentially revealing a unique 
genetic regulator that contributes to retinal degenerative diseases. 
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CHAPTER 1: INTRODUCTION TO EYE DEVELOPMENT AND 
DISEASE. 
 
Table 1.1. Common Abbreviations 
Definition Abbreviation 
Retinal Stem Cell RSC 
Ciliary Marginal Zone CMZ 
Ganglion Cell Layer GCL 
Retinal Neural Fiber Layer RNFL 
Inner Nuclear Layer INL 
Inner Plexiform Layer IPL 
Outer Nuclear Layer ONL 
Outer Plexiform Layer OPL 
Inner Segments IS 
Outer Segments OS 
Retinal Pigmented Epithelium RPE 
5-methylcytosine 5mC 
Bruch’s Membrane BM 
Age-Related Macular Degeneration AMD 
Choroidal Neovascularization CNV 
DNA methyltransferase Dnmt 
Dual-Specificity Phosphatase Dusp 
Retroelements RE 
Micro-RNA miRNA 
Tri-phosphorylated RNA 3pRNA 
Gap junctions GJ 
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1.1 Ocular development and maturation. 
The vertebrate retina is a complex organ, which derives from the embryonic forebrain. 
The overall development and structure of the human eye is recapitulated in other vertebrate 
model organisms such as the mouse and zebrafish1–3. The genetic and morphological 
similarities found in these models provide the necessary tools for studying retinal 
development and disease through genetic perturbations and analyses.  
Retinal development begins when evagination from the diencephalon forms the optic 
vesicles2. Once the optic vesicle contacts the overlying ectoderm, its morphology changes 
and starts the invagination process to create the optic cup (Illustration 1.1)3. Once the optic 
cup is formed, cells within the inner layer begin to differentiate into the neural retina and 
those in the outer layer form the retinal pigmented epithelium (RPE). At early time points, 
the neural retina is comprised of retinal stem cells (RSCs) in a pseudo-stratified epithelial 
structure4. Over time, embryonic  RSCs begin to differentiate into six neural cell types and 
one glial cell type5–7 beginning in the central retina and fanning outward toward the retinal 
periphery8.  
Eventually, mammalian RSCs become confined to the ciliary margin at the most 
peripheral edge of the retina, transition into a quiescent state, and remain inactive 
throughout life9. By comparison, zebrafish RSCs, though also restricted to the peripheral 
region of the retina termed the Ciliary Marginal Zone (CMZ), remain proliferative 
throughout life allowing for continued growth8,10,11. The CMZ contains a mixed population 
of RSCs and retinal progenitor cells that are fated for differentiation and incorporation into 
the neural retina10,12,13. Newly formed neurons and glia first integrate into the neural retina 
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apposed to the CMZ, and as younger neurons continue to be generated, the older cells are 
shifted inward toward the central region of the retina, creating newly differentiated neurons 
in concentric rings4,14,15. The ability of the zebrafish to maintain these RSC populations 
throughout life, and in combination with their genetic tractability, fecundity, and ease of 
genetic manipulation, provides scientists with a unique opportunity to understand RSC 







Illustration 1.1. Diagram of vertebrate optic cup morphogenesis and CMZ maturation.  
A. The optic vesicle begins to invaginate around 16hpf (zebrafish) or E9.0 (mouse) to 
create the optic cup by 22hpf (or E10.0). Cells within the retina begin to differentiate 
between 22-28hpf (E12.). Neural ectoderm (gray). Optic vesicle/cup (purple). B. Enlarged 
diagrams of the dotted square in A. Top: The zebrafish CMZ matures by 72hpf. Note the 
differences in cell and nuclear shape of the CMZ compared to the differentiated neural 
retina at 72hpf. Bottom: The mouse ciliary margin is proliferative during embryonic 
development, and RSCs become quiescent in the ciliary margin. Hours post fertilization 







Figure 1.1. Zebrafish Ciliary Marginal Zone morphology.  
A-B. Transverse cross-section of the zebrafish eye defining the lens and neural retinal 
layers (A) and the Ciliary Marginal Zone (B). C. Enlarged image of the CMZ (white dotted 
rectangle from B). The CMZ is located at the retinal periphery (yellow dotted line). Nuclei 
















1.2 Age-related macular degeneration 
Degenerative ocular diseases affect millions of people worldwide, and within 
developed countries, one of the more predominant diseases reported is age-related macular 
degeneration (AMD)16,17. AMD can be categorized as geographic atrophy (dry AMD) or 
exudative (wet AMD). Dry AMD is the more common form of the disease, and its 
pathology is first characterized through degeneration of the RPE in the central retina, 
closely followed by death and degeneration of the apposed photoreceptors18. Wet AMD 
however, denoted by infiltration of the choroidal vasculature into the retina, termed 
choroidal neovascularization (CNV)16. The most prominent indication of AMD onset and 
correlated geographic atrophy is the buildup of drusen, membrane-rich deposits between 
the RPE and Bruch’s membrane19, or as reticular pseudodrusen between photoreceptors 
and the RPE20,21. Although the mechanisms underlying the development of AMD are still 
unclear, scientists in the field theorize that this is caused by chronic inflammation22,23, a 
common correlating phenotype associated with epigenetic dysregulation24–26. This study 
focuses on both an epigenetic pathway, DNA methylation, and genetic perturbation of the 
microRNA (miRNAs) pathway within the eye. 
 
1.3 Epigenetic and genetic regulation of the retina. 
A common trait of many degenerative diseases is aberrant epigenetic regulation27,28. 
The concept of epigenetics denotes the potential of a single genomic sequence producing 
one or more differing phenotypes29,30. These alterations can be driven by a variety of 
cellular signals including histone methylation31 and DNA methylation32. These epigenetic 
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mechanisms work in combination to regulate tissue development33,34, differentiation35,36, 
and maintenance37–39.  
 
1.3.1 DNA methylation pathway 
DNA methylation involves the addition of a methyl group to the 5th position of the 
cytosine bases to create 5-methylcytosine (5mC). This process is catalyzed by a family of 
enzymes termed DNA methyltransferases (dnmts) (Illustration 1.2) .40,41 Removal of DNA 
methylation is accomplished through a variety of proposed pathways extending from 
replication-dependent passive dilution to enzymatic removal42,43. Although this part of the 
DNA methylation pathway has been shown to be important for intercellular signaling and 
differentiation44,45, the processes of demethylation are not addressed within this study.  
Instead, this study (specifically Chapters 2 and 3) focuses on the enzymes responsible for 
defining these landscapes. 
DNA methyltransferases fall within two main categories: de novo and maintenance. De 
novo dnmts (Dnmt3 family) function to add the initial methylation mark to cytosine 
bases46,47, and the maintenance of this mark is propogated by Dnmt1 during DNA 
replication (Illustration 1.2).48–50 Previous studies have identified numerous processes that 
are affected by changes in the DNA methylome, for example gene expression51,52, 
chromatin accessibility53, transcription factor binding54,55, and silencing of transposable 
elements56,57. Additionally, the location of 5mC marks within the genome also partially 
determines how this epigenetic mark will modulate gene expression.  
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Genes containing high levels of 5mC at their transcription start sites and enhancer 
elements are inversely correlated with expression54,58, whereas intragenic 5mC is positively 
correlated with expression59,60. This creates a cell-type specific methylome that is specific 
to the identity of that particular cell and tissue. In mammals, DNA methylation is critical 
for development61–64, and loss-of-function mutations in Dnmt3a and Dnmt3b often result 
in tumorigenic phenotypes65–69. Moreover, genomic hypomethylation in vitro is  correlated  
with  premature  differentiation70,71  and defects in chromosomal organization, which can 
have wide-ranging effects on gene expression and regulation72–74. Studies have also 




Illustration 1.2. DNA methylation pathway.  
Box: List of DNA methyltransferase genes in the zebrafish (left) across from the 
mammalian orthologue (right). The addition of methyl groups to DNA catalyzed by dnmt3 






1.3.2 Regulation of microRNA and endogenous retroviral expression 
Small noncoding RNAs function to cooperate with epigenetic modifications to regulate 
gene expression through either specific or non-specific targeting of genic mRNAs78. These 
consist of 1) small interfering (si)RNAs and miRNAs produced through the Dicer 
pathway79 and 2) the gonadal-specific PIWI-associated (pi)RNAs80 which act to repress 
endogenous retroelement (RE)81–83 activity.  
Canonical miRNAs originate from a single poly-cistronic RNA containing multiple 
primary miRNA templates84 (Illustration 1.3) and are typically transcribed by the RNA 
Polymerase II enzyme85. However, non-canonical miRNAs often lie within REs which 
contain sequence elements that are specific to RNA Polymerase III activity86. Early 
processing of primary miRNAs occurs in the nucleus where they are trimmed by the 
microprocessor complex containing the Drosha and DGCR8 proteins87,88. This produces a 
precursor miRNA product that is exported from the nucleus and processed by the Dicer 
complex to yield the final ~22 nucleotide double-stranded miRNA89. Previous work has 
demonstrated that effective processing of miRNA requires Dicer’s ability to recognize and 
bind the 5’ tail90. Once associated with Dicer, the duplex associates with the Argonaute 
(Ago) protein to form the RNA-induced silencing complex (RISC)91–93. While in this 
complex, one of the two RNA strands is selected to remain associated with Ago and the 
other is released for degradation. The Ago protein is then guided by the final miRNA 
product to target and downregulate gene transcripts94,95. 
The degree to which a miRNA modulates gene expression is dependent upon its 
sequence specificity. miRNAs with perfect sequence complementarity, when bound to the 
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Ago complex, will lead to cleavage of the target mRNAs. Alternatively, if miRNAs are not 
perfectly complementary, then their association with the Ago complex will sequester the 
target mRNAs from translational machinery96,97. It is through this sequence specificity that 
miRNAs are able to modulate gene expression, including mRNA levels of epigenetic 
regulators whether it is of histone modifiers98–100 or DNA methylation enzymes95,101,101–103, 
demonstrating a link between these two mechanistic pathways. Disruption of miRNA 
association with either the nuclear Drosha/DGCR8 complex or cytoplasmic Dicer/Ago 
complex can result in aberrant gene expression and differentiation104–106, tumorigenesis107, 
or degenerative diseases108–111. Furthermore, the Dicer/miRNA pathway has been 




Illustration 1.3. RNA polymerase III generated miRNA pathway.  
A: Legend of the miRNA pathway components. B. Diagram of the miRNA pathway.. 
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1.3.3 Retroelement contribution to neurodegenerative disease 
miRNAs and epigenetics play a crucial role in how the genome functions and genes are 
regulated and, in doing so, ultimately affect how a cell responds to stress. As stated 
previously, DNA methylation and miRNAs are crucial players in these processes and 
disruption of either are known to have detrimental effects61,108,113. Critically, they are also 
required for proper regulation of REs. REs are a subset of ancient viral sequences contained 
within mammalian DNA and constitute over 40 percent of the human genome114. Many 
REs maintain the potential to “jump” or transpose themselves into novel locations in the 
genome thus having detrimental effects on cellular function. Additionally, overexpression 
of REs is causal to increases in inflammation, a feature of multiple neurodegenerative 
disorders to include Alzheimer’s115,116, hereditary sensory and autonomic neuropathy type 
IE117, and Creutzfeldt-Jakob disease118.  
Previous reports have demonstrated a requirement for DNA methylation113,119,120 and 
miRNAs104,121,122 in proper gene regulation within the retina. Defects in either of these 
regulatory pathways are tightly correlated with RE overexpression, increased 
inflammation, and the onset of degenerative eye diseases to include retinoblastoma107 and 
age-related macular degeneration (AMD)108,123. Currently, there are no known cures for 
AMD and therapies are limited. Therefore it is necessary to increase our understanding of 
how these pathways contribute to degenerative eye disease and can inform the 
ophthalmology field when developing novel therapeutic strategies. 
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CHAPTER 2: DNMT1 IS REQUIRED TO MAINTAIN RETINAL 
STEM CELLS IN THE CILIARY MARGINAL ZONE: 
Portions of this Chapter are modified with permission from the following article: 
Angileri, K.M., Gross, J.M., 2020. dnmt1 function is required to maintain retinal stem 
cells within the ciliary marginal zone of the zebrafish eye. Scientific Reports (in revision).  
KMA conducted all experiments. KMA wrote and KMA and JMG edited the manuscript. 
2.1 Introduction 
The distal region of the vertebrate retina, termed the ciliary marginal zone (CMZ), 
contains a population of resident retinal stem cells (RSCs). The CMZ remains proliferative 
throughout the life of fish, but it proliferates to a more limited extent during the lifetime of 
amphibians and birds8,10,124–127. Whether an analogous structure exists in mammals is 
debated, but there are distinct, progenitor-like cells in the periphery of the retina that are 
active during embryogenesis5,7,128.  Mammalian RSCs can also be isolated from the adult 
ciliary margin, cultured in vitro, and stimulated to produce retinal neurons129–132. However, 
this activity has not been demonstrated in the mature mammalian retinae in vivo.  
Studies of the CMZ have primarily focused on zebrafish and Xenopus models to 
determine genetic pathways required for RSC identity13,125,133,134 and to characterize the 
epigenetic networks which regulate RSC function135,136. By comparison, the mechanisms 
mediating RSC maintenance in vivo remain unknown. In studies of RSCs, the zebrafish 
has been advantageous given that it possesses a highly active RSC population and is 
tractable for genetic and pharmacological manipulations, transgenesis and in vivo 
imaging137,138.  
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DNA methylation, a frequently studied epigenetic modification, is the process through 
which a methyl group is added to the fifth carbon of cytosine nucleotides and is commonly 
found at CpG dinucleotide sequences139. Members of the family of DNA methyltransferase 
(Dnmt) enzymes41,140 catalyze this epigenetic modification. Dnmt1 serves as a maintenance 
methyltransferase, copying the methylation pattern from parent to daughter strand during 
DNA replication and its function is required for cell cycle progression35,141,142. Loss of 
Dnmt1 function results in genomic hypomethylation70,120,143 and in developmental contexts 
and specific organ systems, this often compromises progenitor cell maintenance35,120,144–147 
through numerous cellular mechanisms. These include: inducing cell cycle arrest148,149, 
retroelement activation56,57,150,151, inflammatory responses24,56,147, aberrant 
differentiation70,74,145,152–154 and/or p53-mediated apoptosis148,149.  
Utilizing the dnmt1s872 mutant zebrafish allele144, a widely used catalytically 
inactive point mutant, we establish an in vivo requirement for dnmt1 in RSCs. Through our 
analyses, we identify a decrease in overall RSC numbers, reduced RSC proliferation and 
aberrant gene expression patterns within the dnmt1-deficient CMZ. Additionally, we note 
increased retroelement expression and increased retrotransposition activity in dnmt1-/- 
embryos. Remarkably, RSCs in dnmt1-/- embryos are eliminated in a p53-independent 
manner, suggesting that dnmt1 represses alternative, non-apoptotic cell death pathways in 
RSCs. Taken together, these data highlight a novel function for dnmt1 in maintaining stem 





2.2.1. DNMT1 MUTANTS POSSESS DEFECTS IN THE CILIARY MARGINAL ZONE.  
Previously, we identified a requirement for dnmt1 in maintaining lens epithelial cell 
viability using dnmt1s872 mutant zebrafish120. During these previous studies, we also 
detected photoreceptor layer abnormalities, similar to those documented in Dnmt1-/- 
conditional knockout mice113,119, and an apparent defect in the CMZ. With an interest in 
the role that dnmt1 plays in maintaining RSCs in vivo, here, we focused further on the CMZ 
phenotype. Using DAPI to label and count retinal nuclei, we confirmed a progressive 
degeneration of CMZ morphology beginning at 4 days post fertilization (dpf; Figure 2.1A-
F) and a significant decline in retinal cell numbers through 5dpf (Figure 2.1G).  
The total number of cells present within central retina sections are equivalent between 
dnmt1-/- and sibling larvae at 3dpf; however, numbers in dnmt1-/- larvae diminish 
significantly between 4 and 5dpf (18.8% and 26.6% reduction respectively; p <0.0005; 
Figure 2.1G). Additionally, we compared the proportions of nuclei within the ganglion cell 
layer (GCL), inner nuclear layer (INL), outer nuclear layer (ONL), and CMZ between 
dnmt1-/- larvae and siblings from 3-5dpf (Figure 1H). Interestingly, the proportions of cells 
in all three retinal laminae (GCL, INL, & ONL) remained equivalent over time in dnmt1-/- 
larvae when compared to siblings, with only a slight increase in the ONL at 4dpf (Figure 
2.1H and Figure 2.2A-C; p <0.005). In contrast, the CMZ proportion decreased 
significantly from 3-5dpf suggesting that dnmt1 function in the retina is required within 
the CMZ to maintain the RSC population (Figure 2.1H and Figure 2.2D; p <0.0005). 
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Figure 2.1. Disruption of dnmt1 function results in CMZ defects.  
A-F. DAPI staining of nuclei (gray) within the CMZ (white dotted lines delineate CMZ 
boundaries) of siblings (A-C) and dnmt1-/- (D-F) larvae from 3-5dpf. G. Average number 
of all nuclei within the central retina of siblings and mutants. Each data point is the average 
of cell counts from three different 12 μm sections in one eye of a single larva. H. 
Proportional changes of dnmt1-/- retinal domains (GCL, INL, ONL, & CMZ) relative to 
siblings (set to 100%). Colors correspond with retinal domains in diagram. Scale bars = 30 





Figure 2.2. Loss of dnmt1 function results in a decline of RSC number.  
A-D. Graphs of retinal domain proportions over time between siblings and dnmt1-/- larvae. 










2.2.2 CELL DEATH IS ELEVATED IN THE DNMT1-/- CMZ IN A P53-INDEPENDENT MANNER.  
Previous publications have demonstrated increased p53 expression and TUNEL+ cells 
in Dnmt1-deficient tissues and cell types144,148,149,155 suggesting a p53-dependent apoptotic 
mechanism for cell loss. Based on these studies, we hypothesized that dnmt1-/- RSCs would 
similarly undergo p53-dependent apoptosis. To test this hypothesis, we first assayed for 
the presence of DNA double-strand breaks in dnmt1-/- and sibling retinae using TUNEL 
(Figure 2.3A-F). dnmt1 siblings displayed few TUNEL+ cells between 3-5dpf (Figure 
2.3L-N), whereas the dnmt1-/- retina contained increased proportions of TUNEL+ cells at 
3, 4, and 5dpf in the INL (+0.5-2.3%, p <0.05), ONL (+0.01-1.8%, p <0.05) and at 5dpf in 
the GCL (+1.3%, p <0.05; Figure 2.3H-I). Within the CMZ, we detected a 4.5% increase 
in TUNEL+ cells at 3dpf (p <0.005, Figure 2.3J) prior to the onset of CMZ disorganization. 
This proportion decreased to 1% at 4dpf (p <0.05) and increased again to 3.7% at 5dpf (p 
<0.05; Figure 2.3J), a time at which dnmt1-/- larvae begin to display severe systemic 
defects. During this 3-5dpf period, the majority of TUNEL+ cells in dnmt1-/- larvae were 
located within the retina proper, not within the CMZ (Figure 2.3K and Figure 2.5). In 
concordance with the TUNEL data, immunofluorescence of the pro-apoptotic marker, 
active-caspase3, displayed similar patterns to TUNEL (data not shown). Together, these 
data are consistent with those seen in previous studies; dnmt1 deficiency results in 




Figure 2.3. Cell death is elevated in the dnmt1-/- CMZ.  
A-F. dnmt1 sibling (A-C) and mutant (D-F) retinae labeled with DAPI (gray; nuclei) and 
TUNEL (magenta; dsDNA breaks) from 3-5dpf. G-J. Proportion of retinal layers (GCL, 
INL, ONL, and CMZ) labeled by TUNEL staining. K. Proportion of TUNEL+ cells within 
each layer from 3-5dpf. L-N. Average number of TUNEL+ cells in each retinal layer of 
siblings and dnmt1-/- larvae from 3-5dpf. Yellow arrows in A-F indicate TUNEL+ nuclei. 
Scale bars = 30 µm. *p <0.05, **p <0.005, ***p <0.0005, ****p <0.00005. Dorsal is up 










To identify if dnmt1 deficient RSCs are lost via p53-dependent apoptosis, we generated 
dnmt1;p53 double mutants using the p53zdf1 allele, which is defective in p53-dependent 
apoptosis156,157. We hypothesized that p53-dependent apoptosis was the driving mechanism 
of RSC loss in dnmt1-/- mutants and therefore loss of p53 activity would rescue the CMZ 
phenotype. To test this hypothesis, we quantified nuclei in dnmt1+/+;p53+/+, dnmt1+/+;p53-
/- , dnmt1-/-;p53+/+ and dnmt1-/-;p53-/- retinae (Figure 2.4).   
Loss of p53 function did not affect retinal morphology (Figure 2.4A,E,I compared to 
Figure 2.4B,F,J) and dnmt1+/+; p53-/- mutants possessed equivalent retinal cell numbers as 
dnmt1+/+;p53+/+ siblings (Figure 2.4Q-T and Figure 2.5D) at 3, 4 and 5dpf. When 
considering dnmt1-/-;p53-/- larvae, we predicted an increase in CMZ cell numbers and a 
rescue of the CMZ-specific phenotype when compared to dnmt1-/-; p53+/+ larvae. 
Surprisingly, the dnmt1-/-;p53-/- CMZ displayed similar morphology (Figure 
2.4C,D,G,H,K,L) and was proportional to the dnmt1-/-; p53+/+ sibling retina (Figure 2.4P) 
across all three time points. These results suggest that p53-dependent apoptosis is not 




Figure 2.4. Loss of p53 function does not rescue the dnmt1-/- CMZ phenotype.  
A-L. Transverse sections of the dorsal CMZ in wildtype (A, E, I), dnmt1+/+;p53-/- (B, F, 
J), dnmt1-/-;p53+/+ (C, G, K), dnmt1-/-;p53-/- (D, H, L) larvae from 3-5dpf. Nuclei labeled 
with DAPI (gray) and F- actin labeled with phalloidin (magenta). M-P. Graphs depicting 
changes in retinal domain proportions over time. Q-T. Number of nuclei in each retinal 
domain of dnmt1+/+;p53+/+, dnmt1+/+;p53-/, dnmt1-/-;p53+/+, and dnmt1-/-;p53-/- larvae from 
3-5dpf. GCL: ganglion cell layer; INL: inner nuclear layer; ONL: outer nuclear layer; 
CMZ: ciliary marginal zone. Scale bars = 25 μm. *p <0.05; **p <0.005; ***p <0.0005; 
****p <0.00005. Dorsal is up in all images. 
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Figure 2.5. p53-mediated apoptosis is not responsible for dnmt1-/- RSC loss.  
A-C. Proportion of TUNEL+ nuclei in each retinal domain of dnmt1-/- larvae (gray bars) 
compared to sibling controls (white bars) at 3dpf (A), 4dpf (B), and 5dpf (C). D. Total 
number of retinal nuclei between dnmt1+/+;p53+/+ (white bars), dnmt1+/+;p53-/- (light gray 
bars), dnmt1-/-;p53+/+ (dark gray bars), dnmt1-/-;p53-/- (blue bars) larvae from 3-5dpf. GCL: 
ganglion cell layer; INL: inner nuclear layer; ONL: outer nuclear layer; CMZ: ciliary 





2.2.3 DNMT1 IS REQUIRED TO MAINTAIN RSC GENE EXPRESSION.  
dnmt1 is expressed in RSCs at 4dpf (Figure 2.6I,J), consistent with dnmt1’s known 
requirements in stem cell populations in vivo37,120,144,145,158. Loss of Dnmt1 function results 
in aberrant gene expression in a number of contexts117,119,158,159 and therefore we wanted to 
determine if CMZ-specific gene expression was altered in the dnmt1-/- CMZ. Previous 
reports have characterized the expression/distribution of the CMZ-specific genes: 
col15a1b, cyclinD1, cdkn1c, and atoh7133,134,160. To determine if CMZ expression of these 
genes was altered in dnmt1-/- larvae, we utilized whole-mount in situ hybridization at 4dpf 
when the morphological defects in the CMZ begin to manifest (Figure 2.1). All sibling 
controls displayed normal CMZ-specific gene expression at 4dpf (Figure 2.6). Expression 
of col15a1b and atoh7 were normal in dnmt1-/- larvae (Figure 2.6C,D,S,T); however, the 
expression of ccnD1 and cdkn1ca, which function to regulate cell cycle progression, were 
disrupted (Figure 2.6G,H,O,P).  The majority of 4dpf dnmt1-/- CMZs maintained dnmt1 
expression (Figure 2.6K,L). These data suggest that RSCs are present at the onset of 
morphological defects in the dnmt1-/- CMZ, but could be impaired in their ability to 
progress through the cell cycle and self-renew.  
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Figure 2.6. dnmt1 is required to maintain RSC gene expression.  
Gene expression shown in whole mount (A, C, E, G, I, K, M, O, Q, S) and transverse 
cryosections (B, D, F, H, J, L, N, P, R, T) between siblings and dnmt1-/- larvae. A-D. 
col15a1b expression. E-H. ccnD1 expression. I-L. dnmt1 expression. M-P. cdkn1ca 
expression. Q-T. atoh7 expression. Numbers in transverse cryosections designate the 
number of larvae that showed the displayed expression pattern vs. the total number of 
larvae analyzed. Scale bars = 75 mm (whole mount) and 10 μm (transverse sections). 
Anterior is up in all whole-mounts and dorsal is up for all section images. 
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2.2.4 LOSS OF DNMT1 ACTIVITY RESULTS IN DECREASED RSC PROLIFERATION.  
RSCs within the teleost CMZ remain proliferative throughout the lifespan of the 
animal4,10,14 and Dnmt1 is known to be required for cell cycle progression within stem cells 
of various tissue types35,141,161. Based on the significant loss of RSCs in dnmt1-/- larvae 
between 3-5dpf (Figure 2.1) and the inability of dnmt1-/- RSCs to maintain expression of 
cell cycle genes (Figure 2.6), we hypothesized that dnmt1-/- RSCs would be defective in 
their proliferative capacity. To test this hypothesis, larvae were incubated for 2 hours in 
BrdU at 3, 4, and 5dpf, fixed immediately thereafter, and immunolabeled for BrdU and 
phosphohistone-H3-serine10 (pH3) to identify RSCs in late G2/M. dnmt1 siblings 
maintained a constant proportion of BrdU+ cells within the CMZ between 3-5dpf (Figure 
2.7A-C,H).  
Notably, the proportion of BrdU+ dnmt1-/- RSCs at 3dpf was comparable to sibling 
controls (compare images in Figure 2.7A and 2.7D and nuclear proportions in Figure 2.7G). 
However, beginning at 4dpf, the percentage of BrdU+ dnmt1-/- RSCs is significantly 
reduced when compared to controls (Figure 2.7B,E,H; p <0.00001), and this proportion 
continues to decrease through 5dpf (Figure 2.7C,F,H; p <0.0001). Additionally, the 
proportion of cells in late G2/M phase (pH3+) was significantly reduced at 3 and 4dpf in 
the dnmt1-/- CMZ when compared to siblings (Figure 2.7G,I) indicating potential cell cycle 






Figure 2.7. RSCs require dnmt1 function to maintain proliferation.  
A-F. Transverse sections of siblings (A-C) and dnmt1-/- (D-F) larvae from 3-5dpf. Nuclei 
labeled with DAPI (gray). Cells in S-phase indicated by BrdU incorporation (magenta). 
Mitotic cells are labeled by a pH3(ser10) antibody (cyan). G. Proportions of CMZ cells in 
S-phase (magenta), G2/M-phase (cyan), or not proliferating (gray) of both siblings and 
dnmt1-/-larvae from 3-5dpf. H. Proportion of CMZ cells labeled with BrdU from 3-5dpf 
between controls and dnmt1-/-larvae. I. Proportion of CMZ cells labeled with pH3 from 3-
5dpf between controls and dnmt1-/-larvae. White dotted lines designate CMZ (A-F). Scale 
bars: 30 μm *p <0.05, **p <0.005, ***p <0.0005, ****p <0.00005. Dorsal is up in all 
images. 
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2.2.5 DNMT1 IS REQUIRED FOR RSC DIFFERENTIATION AND INCORPORATION INTO THE 
NEURAL RETINA.  
Potential cell cycle progression defects coupled to the fact that the vast majority of 
dnmt1-/- RSCs elude p53-dependent apoptosis (Figures 2.3 & 2.4) led us to hypothesize 
that dnmt1-/- RSCs might instead be undergoing premature differentiation, as has been 
shown in vitro70. To test this hypothesis, we performed a BrdU birth-dating assay162. Our 
aim was to saturate RSCs with BrdU for a 12-hour period (3-3.5dpf) and quantify the 
average starting number of proliferating cells at 3.5dpf and determine the final position of 
daughter cells at 5dpf, once they incorporated into the retina (Figure 2.8A). Initial analysis 
of these samples revealed that most BrdU+ nuclei in both sibling and dnmt1-/- larvae were 
located within the CMZ after the 12hr incubation (Figure 2.8C,E,G). However, there were 
a few BrdU+ cells that had incorporated into the neural retina at this time (Figure 2.8G). 
By comparing the number of BrdU+ nuclei of each retinal domain (CMZ, GCL, INL, ONL, 
Figure 2.8B) to the total number of BrdU+ nuclei (Figure 2.8H) at 3.5dpf, we noted a 
significant increase in the proportion of BrdU+ nuclei in the dnmt1-/- CMZ (79.5%, p <0.05) 
compared to controls (71.7%, Figure 2.8G; Figure 2.9A). Additionally, we found that the 
proportion of BrdU+ cells in the dnmt1-/- ONL (7.8%, p <0.05) was significantly reduced 
compared to siblings (10.9%, Figure 2.8G; Figure 2.9A) at 3.5dpf. 
At 5dpf, all BrdU+ cells in the sibling controls had exited the cell cycle and incorporated 
into the neural retina (Figure 2.8D,G), whereas dnmt1-/- larvae retained 19.8% (p =0.05) of 
BrdU+ nuclei within the CMZ and had fewer BrdU+ cells overall within the retina (Figure 
2.8F,G). Additionally, there was a significant decrease in the proportion of BrdU+ nuclei 
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in the GCL (9.8%, p <0.0005) (Figure 2.8G; Figure 2.9B) compared to controls (21.4%). 
Surprisingly, among the cells that remained in the 5dpf dnmt1-/- CMZ, there was an increase 
in the BrdU+ proportion when compared to siblings (19.76% vs. 0.9% respectively, p 
=0.05; Figure 2.8G; Figure 2.9B) suggesting an inability for some RSCs to either 
successfully complete the cell cycle or to integrate into retinal laminae. These data also 
show that daughter cells produced from the dnmt1-/- CMZ proportionally incorporate into 
the INL and ONL at similar levels to those detected in controls (Figure 2.8G; Figure 2.9B) 
supporting the notion that dnmt1-/- RSCs are still capable of producing neurons that can 
























Figure 2.8. Neurons produced by dnmt1-/- RSCs fail to integrate into the neural retina.  
A. Experimental paradigm depicting BrdU incorporation from 3-3.5dpf. Fixations occurred 
at 3.5 & 5dpf. B. Diagram of the four retinal domains (CMZ, GCL, INL, and ONL) whose 
colors correlate with the data presented in G. C-F. Transverse sections of BrdU pulses from 
3-3.5dpf (C,E) and pulse-chase assay from 3-5dpf (D,F) (Siblings: A-B; dnmt1-/- C-D). 
Nuclei labeled with DAPI (gray). Cells in S-phase indicated by BrdU incorporation 
(magenta). Mitotic cells are labeled by a pH3(ser10) antibody (cyan). G. Proportion of 
BrdU+ cells located in each retinal layer at 3.5dpf and 5dpf of dnmt1-/- and control larvae. 
H. Proportion of total BrdU+ cells within the central retina of the pulse-chase experiment. 
White dotted lines designate the CMZ (C-F). Yellow arrows = BrdU+ nuclei outside the 




Figure 2.9. dnmt1-deficient RSCs fail to incorporate into the neural retina.  
A. Data points collected of the proportion of cells labeled with BrdU in each retinal domain 
at 3.5dpf divided by the number of total BrdU+ cells. B. Data points collected of the 
proportion of cells labeled with BrdU in each layer at 5dpf divided by the number of total 












2.2.6 LOSS OF DNMT1 ACTIVITY LEADS TO ALTERED LONG TERMINAL REPEAT 
RETROELEMENT EXPRESSION WITHIN THE CMZ.  
Half of the zebrafish genome is comprised of endogenous viral elements known as 
transposons163,164, and dnmt1 is required for repressing the retroelement (RE) lineage of 
transposons56,165–167. Though many REs have lost their ability to “jump” throughout 
evolution, some still retain this ability168,169. These studies led us to hypothesize that 
aberrant DNA methylation resulting from loss of dnmt1 activity in RSCs would result in 
upregulation of RE expression within the dnmt1-/- CMZ. To identify RE expression within 
the CMZ, we performed in situ hybridizations targeting several REs that belong to the Long 
Terminal Repeat (LTR) class of retrotransposons, specifically Bel20, ERV1, ERV1-N5, 
ERV4, and Gypsy10 LTRs. We noted endogenous expression of Bel20, ERV4, and Gypsy10 
REs within the CMZ but not the neural retina of control larvae at 4dpf (Figure 2.10A,D,E).  
This result was unexpected since REs can be deleterious to cellular function56,170–172. 
However, not all of the LTR REs were detected within control CMZs; ERV1 and ERV1-
N5 expression was not detected in the CMZ of siblings (Figure 2.10B,C), but rather ERV1-
N5 seemed to be expressed within the ONL of some control larvae (Figure 2.11O). 
Remarkably, dnmt1-/- larvae had increased expression of ERV1-N5 in the CMZ and within 
the overlying retinal pigmented epithelium (Figure 2.10H). The expression domains of 
Bel20 and ERV4 were expanded beyond the CMZ and into the neural retina of dnmt1-/- 
larvae (Figure 2.10F,I) when compared to controls. Of note, we also identified several non-
ocular tissues that displayed altered RE expression between dnmt1-/- and sibling control 
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larvae (Figure 2.11). Interestingly, these LTR RE expression patterns were larvae-
















Figure 2.10. Loss of dnmt1 function results in misregulation of retroelement expression.  
A-J. Transverse cryosections of sibling (A-E) and dnmt1-/- (F-J) larvae at 4dpf. A, F. 
Expression of Bel20 LTR. B, G. Expression of ERV1 LTR. C, H. Expression of ERV1-N5 
LTR. D, I. Expression of ERV4 LTR. E, J. Expression of Gypsy10 LTR. Dotted lines: 










Figure 2.11. Loss of dnmt1 function results in misregulation of LTR RE expression 
across numerous tissues.  
A-X. Transverse cryosections of larvae analyzed by in situ hybridization. All sibling and 
dnmt1-/- larvae are 4dpf. A-H. Expression of indicated REs within the lower jaw. I-N. 
Expression of indicated REs within the upper jaw. O-P. Expression of ERV1-N5 LTR in 
photoreceptors (O; sibling) and the RPE (P; dnmt1-/-). Q-R. Expression of Bel20 LTR 
within the brain. S-X. Expression of indicated REs within the cornea. Arrows delineate 
expression changes of specified REs. Scale bar (A) = 10 μm. All images were taken at the 











2.2.7 A L1RE3-EGFP TRANSGENE REPORTS INCREASED LINE1 RETROTRANSPOSITION 
ACTIVITY IN DNMT1-/- CMZ. 
To expand our analysis of RE expression in dnmt1-/- RSCs, and more specifically, 
visualize retrotransposition activity in vivo, we generated a non-LTR, LINE1 element 
transgenic reporter line by modifying the pLRE3-EGFP plasmid173,174 (referred to as 
L1RE3-EGFP for the remainder of this study). The L1RE3-EGFP construct contains a 
human-derived LINE1 RE sequence that requires retrotransposition for EGFP to be 
expressed and translated into a functional protein173. p53 is known to repress REs and when 
used transiently in p53-/- zebrafish, L1RE3-EGFP was shown to have increased 
transposition activity and EGFP expression172. We validated the stability and effectiveness 
of the L1RE3-EGFP transgenic using again p53 mutants156,172 and immunolabeling for 
EGFP (Figure 2.12A).  
When L1RE3-EGFP was incorporated into the dnmt1s872 genetic background, ectopic 
EGFP expression could be seen within the dnmt1-/- eye when compared to control siblings 
(Figure 2.13B,C). Notably, we detected ectopic EGFP expression more frequently within 
the dnmt1-/- CMZ at both 3dpf (Figure 2.13C) and 4dpf (Figure 2.13D) time points when 
compared to controls (Figure 2.13A,B). However, like RE expression, clonal EGFP 
expression patterns were variable, both within and between sibling controls and dnmt1-/- 
larvae, again suggesting that the effects of dnmt1 loss is variable from cell to cell and larva 




Figure 2.12. L1RE3-EGFP transgene expression is more prominent in dnmt1-/- larvae.  
A-A’’. Transverse section of Tg(CMV:Hsa.L1RE3,EGFP,myl7:EGFP;p53-/-) larvae at 
4dpf. A. L1RE3-EGFP+ retinal cells labeled with endogenous EGFP. Cyan (A‘) and yellow 
(A’‘) dotted boxes indicate magnified images to the right of panel A. A’. Magnified image 
of Tg(CMV:Hsa.L1RE3,EGFP,myl7:EGFP;p53-/-) CMZ showing no expression of the 
L1RE3-EGFP transgene. A’’. Magnified image of retinal neuron expressing L1RE3-EGFP 
transgene. B-I. All images are taken from Tg(CMV:Hsa.L1RE3,EGFP,myl7:EGFP) larvae 
that are either dnmt1+/+ (B,D,F,H) or dnmt1-/- (C,E,G,I). B-C. Whole-mount images of 4dpf 
eyes demonstrating L1RE3-EGFP transgene activation seen through the lens of dnmt1-/- 
larvae and not siblings. D,F,H. Sibling larvae expressing the L1RE3-EGFP transgene in 
the brain. E,G,I. dnmt1-/- larvae expressing the L1RE3-EGFP transgene in the brain. Nuclei 
labeled with DAPI (gray). Endogenous L1RE3-activated EGFP labeled in green. EGFP 




Figure 2.13. RSCs require dnmt1 function to repress L1RE3-EGFP transposition.  
A-D. Transverse sections of Tg(CMV:Hsa.L1RE3,EGFP,myl7:EGFP;dnmt1+/+) (A-B) 
and Tg(CMV:Hsa.L1RE3,EGFP,myl7:EGFP;dnmt1-/-) (C-D) larvae at 3dpf (A, A’, C, C’) 
and 4dpf (B, D). Nuclei labeled with DAPI (gray). Endogenous EGFP expression activated 
after L1RE3-EGFP transposition labeled in green. Arrows delineate EGFP+ cells. Scale 









The zebrafish, with its lifelong, actively cycling RSCs within the CMZ, is a powerful 
model through which we can address how epigenetic regulators function to maintain these 
stem/progenitor cell populations in vivo. This study focused on the role of the DNA 
maintenance methyltransferase, dnmt1, within the CMZ, with the goal of determining how 
dnmt1 activity facilitates RSC maintenance. Previous work has shown that loss of dnmt1 
function results in ocular defects113,119,120,159, but no studies have yet analyzed RSC 
populations and determined whether dnmt1 activity modulates their behavior.  
Here, we demonstrate that dnmt1 is essential for RSC homeostasis by maintaining 
CMZ-specific gene expression (Figure 2.6), facilitating cell cycle progression (Figure 2.7), 
and incorporation of CMZ-derived cells into the retina (Figure 2.8). These data are 
consistent with Dnmt1 functions described in other in vivo progenitor models such as the 
lens120, hippocampus158, kidney166, pancreas144 and intestine37. RSCs in S- and G2/M-
phases of the cell cycle were detected in reduced proportions in the dnmt1-/- CMZ and this 
correlated with a reduction in CMZ expression of genes encoding proteins that function in 
cell cycle progression, namely ccnD1 (Figure 2.6G-H) and cdkn1ca (Figure 2.6O-P). 
Defects in cell cycle progression may also contribute to aberrant daughter cell integration 
into retinal laminae detected in dnmt1-/- larvae (Figure 2.8). Although our data demonstrate 
an overall loss of RSCs and their progeny, this RSC depletion is independent of the p53-
driven apoptotic pathway (Figures 2.3 and 2.4) signifying additional mechanisms of cell 
loss are at play.  
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While loss of p53 function in the dnmt1-/- background significantly rescued cell death 
within the laminated retina, validating that the p53zdf1 allele is in fact inhibiting p53-driven 
apoptosis, loss of p53 in the dnmt1-/- CMZ had no effect on CMZ cell numbers suggesting 
a p53-independent cell death pathway is likely modulated by dnmt1 in the CMZ175. Recent 
reports have demonstrated an upregulation of an innate inflammatory response in dnmt1-/- 
larvae56. Necroptosis, a programmed cell death pathway tightly linked to a cell’s innate 
viral detection system and inflammatory responses, also results in DNA fragmentation and, 
in its later stages, is detected by TUNEL175. Accordingly, we considered the possibility that 
dnmt1-/- RSCs were instead lost via necroptosis. We tested this hypothesis using several 
chemical inhibitors of necroptosis, some of which have been reported to function in the 
zebrafish176,177; however, we were unable to replicate necroptotic inhibition nor validate 
drug efficacy.  None the less, we predict that either necroptosis or pyroptosis (a 
programmed cell death pathway triggered by intracellular bacterial infections178,179) are the 
most likely mechanisms of cell death in dnmt1-deficient RSCs, but this will require the 
development of new tools to enable further analysis.  
Alterations in RE expression activity the dnmt1-/- CMZ (Figures 2.10 and 2.13) are 
exciting given Dnmt1’s known roles in repressing RE activity56,57,150,151. RE expression 
was aberrant in most dnmt1-/- CMZs examined (Figure 2.10); however, expression changes 
and levels were variable between larvae, suggesting that the location and extent of genomic 
hypomethylation resulting from loss of dnmt1 function is inherently variable between cells 
of each larva. Previous reports demonstrated innate RE activity within healthy somatic 
neural tissue168,169,180–182. Indeed, we detected retrotransposition activity within the larval 
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zebrafish brain (Figure 2.13D-I) of both siblings and dnmt1-/- larvae from 2-4dpf, similar 
to activity detected in human hippocampal neurons168,169,182. Notably, some REs were 
found to be expressed within sibling control tissues and down-regulated in the dnmt1-/- 
larvae (Figure 2.11). These data, along with the recent studies in the human 
brain168,169,180,182, suggest that expression of some REs is a normal occurrence. Moreover, 
it is increasingly apparent that certain REs have functional roles within the cell183,184, 
indicating a vertebrate cooption of RE acquisitions throughout evolutionary history.  
Detection of active RE retrotransposition using the CMV:Hsa.L1RE3,EGFP construct 
is highly variable between larvae (Figure 2.13), and is likely a result of 1) its starting 
location within the transgenic line, 2) levels of genomic methylation at that locus, and 3) 
cell type-specific factors and response to loss of DNA methylation. Further studies will be 
required to determine what cellular processes might sensitize a cell- or tissue-type to 
upregulate REs and whether these REs have a mechanistic purpose within the cell.  
In conclusion, our results demonstrate that dnmt1 functions to maintain RSC 
proliferation, gene expression, and integration of RSC daughters into the retina. 
Additionally, some REs are innately expressed within RSCs, however dnmt1 function is 
required to maintain tight control of these viral elements. Without dnmt1 activity, LTR 
expression remains active within the retina and L1RE3-EGFP retrotransposition activity is 
increased. Interestingly, RE activity within RSCs does not result in p53-mediated 
apoptosis, supporting a model in which dnmt1-/- RSCs are lost through another mechanism 
of cell death. As discussed above, we predict that this increase in RE activity most likely 
activates necroptotic or pyroptotic cell death pathways, which are both known to result 
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from intracellular responses to invading pathogens175,178,179. Regarding the innate LTR 
expression within dnmt1+/+ RSCs, in conjunction with previous reports of inherent RE 
activity within human neural tissue, it is worth considering how RE activity may contribute 
to neural stem cell biology. It is well known that dysregulation of REs is a hallmark of 
many human neurodegenerative diseases27,171,185–187. Future evaluations regarding the 
innate cost-to-benefit ratio of RE activity could provide crucial evidence for the 















CHAPTER 3: DISRUPTION OF DE NOVO DNMT PARALOGS DOES 
NOT AFFECT RETINAL DEVELOPMENT: 
 
3.1 Introduction to de novo DNA methylation. 
As discussed in the previous chapter, dnmt1 is responsible for copying DNA 
methylation patterns from parent to daughter strands of DNA during replication. However, 
nascent methyl groups can be added to cytosine bases through the catalytic action of de 
novo DNA methyltransferases140,188. The Dnmt3α and Dnmt3β family of enzymes mediate 
this catalytic reaction61. Disruption of the methylome can result in aberrant gene and 
miRNA expression76,95,101,189, premature differentiation68,71,190, activation of endogenous 
retroelements191,192 (REs), tumorigenesis66,69,193, and embryonic lethality61,71.  
Although there are numerous studies of DNA methylation function in vitro and in vivo, 
those regarding studies of eye development, differentiation, and disease are limited. Within 
the eye, tissue-specific disruption of combinatorial mutants for Dnmt1, Dnmt3α, and/or 
Dnmt3β function leads to aberrant photoreceptor differentiation and synapse 
formation113,119. Moreover, dnmt1 is known to be required for lens progenitor cell 
maintenance120. Nonetheless, our current understanding of de novo methyltransferase 
function within the mammalian eye has been limited, and studies using non-mammalian 
model organisms have been limited to chemical manipulation50,141,194 or morpholino-based 
gene knockdowns159,195.  
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Due to genome duplication events in the evolutionary history of the zebrafish, its 
genome contains six paralogs of dnmt3 in comparison to the two paralogues found in 
mammals41,196. Of these, two are orthologues of Dnmt3α, three are orthologues of Dnmt3β, 
and the last is distinct from mammalian Dnmt3s (Illustration 1.2)197,198. Recently, our 
laboratory published a study on de novo dnmts demonstrating that all six paralogs are 
expressed within the developing zebrafish eye and display tissue-specific expression 
patterns199. Of note, four of the dnmts (dnmt3βa, dnmt3βb.1, dnmt3βb.2, and dnmt3βb.3) 
are expressed within the zebrafish CMZ, suggesting they might play a role in RSC 
maintenance and/or function. Additionally, de novo dnmts play a role in gene expression 
changes and cellular differentiation71,190. Based on this knowledge, we hypothesized that 
dnmt3 methyltransferases would provide critical insight into their role of de novo 
methylation during retinal development and differentiation. 
Taking advantage of the genetic tractability and fecundity of the zebrafish to our 
advantage, we generated mutant alleles in five of the six de novo dnmt genes using 
transcription activator-like effector nucleases (TALENs)200 and clustered regularly 
interspaced short palindromic repeats (CRISPR)-Cas9 mutagenesis201. TALEN- and 
CRISPR/Cas9-directed mutagenesis are common genome-editing tools for creating site-
specific mutations and both are utilized in a variety of model organisms190,202–204. To 
disrupt the function of the remaining de novo dnmt paralogue, dnmt3αa, we acquired the 
dnmt3αasa617 allele from the Zebrafish International Resource Center (ZIRC) and created 
combinatorial genetic mutants of the dnmt3 alleles described in this chapter. Through the 
creation of frameshift mutants and whole gene knockouts (KOs), we generated different 
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combinations of triple, quadruple, and quintuple mutants. The single and compound alleles 
generated for this dissertation are listed in Table 3.1.  
 
3.2 Results 
3.2.1 FUNCTIONAL ANALYSIS OF DE NOVO DNMTS WITHIN THE CILIARY MARGINAL ZONE. 
To determine how de novo dnmts may be functioning during retinal development, I 
collaborated with Dr. Pawat Seritrakul to create null mutations in five of the dnmt3 genes 
190 ( Figure 3.1). I designed TALEN constructs targeting the 5’ end of both dnmt3βb.2 and 
dnmt3βb.3 genes (Figure 3.1). We hypothesized that since the early zebrafish embryo 
repairs DNA breaks through non-homologous end-joining (NHEJ), the most likely 
mutation to be generated by the TALEN constructs would be frameshift mutations that 















designation Brief allelic description 
Mutagenesis 
Method 
dnmtβb.2 pt702 5bp deletion  TALEN 
dnmtβb.3 pt703 8bp deletion TALEN 




115,375bp deletion & 352bp 
insertion; triple gene knockout 
CRISPR/Cas9 
Target site 1: 
Target site 2: 
dnmtαb# au62 4bp deletion TALEN 
dnmtβa# au63 8bp deletion TALEN 
dnmtαa sa617* Point mutant (G>T) N/A 
* – Allele acquired through ZIRC. 















F0 founders were identified through PCR and Sanger sequencing, then outcrossed to 
create stable lines for the dnmt3βb.2pt702 and dnmt3βb.3pt703 genes (Figure 3.2). Initial 
analyses of both dnmt mutations demonstrated a lack of retinal phenotype (Figure 3.3B-
C). These results were consistent with those reported previously in the dnmt3αb, dnmt3βa, 
and dnmt3βb.1 genes190. Additionally, it was reported that frameshift mutations generated 
through TALEN- and CRISPR-induced frameshift mutations often result in nonsense-
mediated decay (NMD) of the unstable, mutant mRNA transcripts. The zebrafish NMD 
pathway triggers in-frame exon skipping for continued expression206. To bypass the 
nonsense-mediated decay response, I generated a CRISPR/Cas9-mediated gene knockout 
in the dnmt3βb.3pt704 gene (Figure 3.2) by targeting both the 5’ and 3’ end of the gene. This 
would theoretically bypass the mRNA instability associated with the NMD response.  
I successfully generated a stable dnmt3βb.3 knockout (KO) using CRISPR/Cas9 
mutagenesis, which deleted 17,805bp from the genomic sequence of dnmt3βb.3 on 
Chromosome 23. Surprisingly, dnmt3βb.3 KO larvae retained a phenotypically normal 
retina (Figure 3.3C). We hypothesized that the de novo dnmts were functionally redundant 





Figure 3.1. Diagram depicting the six de novo dnmt genes and target sites used in this 
collaborative study.  
Each gene diagram, represented by annotated exons (black boxes) and introns (lines), was 
acquired from the Ensembl genome browser. Genetic distances are not to scale. Colored 
arrowheads depict TALEN or CRISPR/Cas9 target sites used for mutagenesis. The ZMP 
allele (yellow arrowhead) was acquired through the Zebrafish International Resource 
Center. All three dnmt3βb genes annotated with colored dotted lines, which correspond to 
their genetic orientation within Chromosome 23 diagrammed at the bottom of this figure. 




Figure 3.2. Diagram of the de novo dnmt alleles generated.  
All three dnmt3βb genes are oriented consecutively along Chromosome 23. Arrowheads 
depict the target sites and method of mutagenesis based on color. Triple KO sites 
generated using CRISPR/Cas9. Sanger sequencing of each allele is shown (mutant 
sequence is aligned on top of the wildtype sequence) and designates the number of base 
pairs missing from the original genetic sequence.  
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3.2.2 DNMT3 QUINTUPLE MUTANTS LACK A RETINAL PHENOTYPE.  
Based on the de novo dnmt gene expression patterns, our lab had previously 
demonstrated that four of the six de novo dnmts were not required in a pair-wise manner 
for retinal development190. Although these double dnmt mutants did not present with a 
phenotype, this did not negate the possibility that all six de novo dnmts were capable of 
compensating for the loss of another. Thus, we hypothesized that these studies would 
require all six de novo paralogs to be non-functional in order for the larvae to present with 
a phenotype. To begin addressing this possibility, we took advantage of the three dnmt3βb 
genes located in succession along Chromosome 23 (diagrammed in Figures 3.1 and 3.2). 
We generated CRISPR/Cas9 small guide RNAs (sgRNAs) to target the 5’ end of 
dnmt3βb.1 and the 3’ end of the dnmt3βb.3 gene. Injection of both sgRNAs with Cas9 
mRNA into the 1-cell embryo resulted in the deletion of approximately 120,000bp of DNA 
on Chromosome 23. A founder identified by PCR and Sanger sequencing was outcrossed 
to create a stable mutant line, referred to as dnmt3βb.1-3pt705 for the remainder of this 
dissertation (Figure 3.2). Interestingly, dnmt3βb.1-3-/- larvae did not present with any 
apparent phenotype within the retina (Figure 3.3D) nor systematically (data not shown).  
Based on these results, I continued outcrossing each de novo dnmt allele with another 
in an effort to create a sextuple mutant line. I successfully generated adult zebrafish that 
were dnmt3βb.1-3+/-, dnmt3αa+/-, dnmt3αb+/- and dnmt3βa+/- alleles (Figure 3.1). 
Surprisingly, larvae generated from these adults looked phenotypically normal to wildtype 
controls. These larvae were genotyped, and I identified quintuple mutants which also 
lacked a retinal phenotype (Figure 3.3H). We were unable to identify sextuple mutant 
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larvae from these genetic crosses, and clutch sizes were small making the likelihood of 
identifying a sextuple mutant larva difficult. 
The analyses reported in this chapter reveal a lack of overt phenotypes among 
combinatorial de novo dnmt mutants suggesting that these enzymes are functioning 
redundantly. Despite the overtly normal development of quintuple dnmt mutants, the lack 
of phenotypic and/or functional evidence warrants further analyses to determine how these 
enzymes may function in eye development and differentiation. Any conclusive results in 
the future will require continued efforts to generate a sextuple null de novo dnmt line and 








Figure 3.3. Combinatorial de novo mutants do not display aberrant retinal phenotypes.  
A, B, E. Control retinas of wildtype (A), all heterozygous dnmt3βb alleles (dnmt3βb.2, 
dnmt3βb.3, and dnmt3βb.1-3) (B), and a combination of the quintuple alleles (dnmt3βb.1-
3, dnmt3αa, and dnmt3αb) (E). C. Example of dnmt3βb.2-/- or dnmt3βb.3-/- retinae. D. 
Retina of the dnmt3βb.1-3-/- (triple KO) allele. F. dnmt3αb-/- allele as an additional control. 
G. Retina of quadruple dnmt mutant. H. Retina of quintuple dnmt mutant. All images taken 
of 5dpf larvae. Nuclei labeled with DAPI (gray). F-actin labeled with phalloidin (cyan). 





3.3 Discussion:  
Regulation of gene expression and chromosomal interactions across multiple 
organisms, tissues, and cell types is an inherent function of DNA methylation207–209. De 
novo Dnmt genes have been shown to be critical for embryonic development61, yet the field 
is still lacking in our understanding of how precisely this family of dnmts alters the 
genomic landscape in specific tissues or during development. Any malfunction in these 
proteins, and ultimately how that affects genomic methylation patterns, often leads to 
misregulation of gene expression210,211, tumorigenesis65,212, or even cell death213. Known 
mutations within mammalian de novo Dnmts correlate with embryonic lethality61,69,214. 
Moreover, disruption  of the methylome is correlated with multiple neurodegenerative 
diseases, for example Alzheimer’s, Parkinson’s215, and age-related macular 
degeneration165.  
3.3.1 DE NOVO DNMT3S ARE FUNCTIONALLY REDUNDANT. 
Our findings in this chapter are inconclusive, in that we were unable to determine a 
specific role that de novo dnmt3 family members play during retinal development. The 
possibility exists that this is a result of functional redundancy between the dnmt3 paralogs. 
However, there are many unanswered questions in this regard. Firstly, it has not been 
established that all of the mutant alleles are functionally inactive and have bypassed the 
NMD trigger for compensation206. Validating de novo dnmt3 transcript and protein levels 
will provide strong evidence for future analysis, though the sequence and protein 
similarities between these paralogs will require careful consideration. Secondly, if there is 
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functional redundancy, it will be essential to determine if these enzymes work to target the 
same regions of the genome or have site-specific differences. Cofactors that bind Dnmt3s 
could also play a large part in how these proteins are functioning retinal development. 
However, the fact that quintuple mutants lacked any obvious phenotype supports a model 
in which these enzymes are functionally redundant (Figure 3.3). Future studies aimed at 
determining dnmt3 family member function will require careful preparation and genotypic 
analyses, because successful propagation of these combined mutant alleles is a long and 
time-consuming process. 
Knockout of the three dnmt3βb genes lying in tandem on Chromosome 23 enables 
maintenance of these mutants as a single allele (dnmt3βb.1-3pt705). However, maintaining 
and propagating four separate alleles still only produces one sextuple mutant per 256 
embryos. Even with the zebrafish’s high fecundity, the amount of genetic screening 
requires an excessive amount of work. It was attempted to propagate these alleles as mutant 
lines in progressively larger combinations since single and double mutant zebrafish were 
viable. Despite these efforts, the pool of adults carrying the necessary mutant alleles was 
small, and breeding these fish together was much less fruitful than wildtype controls. This 
limited the number of embryos available for experiments and increased the difficulties of 
propagating these mutant alleles together. Whether these breeding inadequacies were due 
to the inbreeding (to acquire the necessary mutant allele combinations), an effect of the 
mutant allelic combinations upon larval development, or fecundity remains to be 
elucidated. Our understanding of how each of these six de novo dnmts may be functioning, 
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either similarly or otherwise, within a cell and how that translates to tissue development 




















CHAPTER 4: CHARACTERIZATION OF DUSP11 FUNCTION IN 




4.1.1: THE DUAL-SPECIFICITY PHOSPHATASE (DUSP) FAMILY OF ENZYMES 
It is widely known that many proteins are modified by the addition of (via kinases) or 
removal of (via phosphatases) phosphate groups and that this modification can alter the 
function of a protein. The Dual-specificity phosphatase (Dusp) family is unique in that they 
have the ability to dephosphorylate both tyrosine and serine/threonine residues216 and have 
demonstrated roles in various cellular processes217–219. Dusp variants are numerous and 
grouped into two main categories: Map-kinase phosphatases and atypical phosphatases220. 
Additionally, reports of Dusp family members have been implicated in activation of the 
innate inflammatory response or increased susceptibility to infection220,221.  
Dusp11 falls within the atypical category, and is the sole member of the Dusp protein 
family that has a unique affinity for 5’-triphosphorylated-RNA substrates (herein referred 
to as 3pRNA)216,222. Dusp11 binds 3pRNAs and removes two of the phosphate groups to 
create mono-phosphorylated RNA (pRNA)222,223. This activity is essential for micro-RNAs 
(miRNAs) to bind to the RNA-induced silencing complex (RISC) complex and regulate 
gene expression90. Recent in vitro studies have demonstrated a critical role for Dusp11 in 
limiting RNA virus replication221,224. Additionally, reported evidence demonstrates an 
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increased inflammatory response in vitro in response to decreased levels of Dusp11 
mRNA225. Indeed, this correlative trend in inflammatory response and Dusp11 mRNA 
levels has been reported in cases of human inflammatory bowel disease patients226, though 
no in vivo mechanistic studies have been demonstrated to date. 
4.1.2: INTRACELLULAR DETECTION AND RESPONSE TO SELF AND NON-SELF 3PRNAS 
3pRNAs are transcribed by RNA Polymerase III and are a common indicator of 
adenoviral or retroviral RNAs216,220. 3pRNAs located within the cytoplasm are therefore 
common indicators of viral infections224,227,228. Once viral RNA is detected, the Pattern 
Recognition Receptors (PRRs) trigger an immune response225,227. Interestingly, RNA Pol 
III also transcribes endogenous REs within the mammalian genome, which consequently 
are labeled by triphosphate groups229,230. This shared feature between REs and infectious 
viral RNAs introduces a conundrum within the cell in which it must distinguish between 
self and non-self elements.  
Pattern Recognition Receptors are part of a cell’s defense against pathogens, and these 
PRRs will trigger an immune response if 3pRNAs are detected227. Alu elements are an 
example of endogenous, non-autonomous REs that are transcribed by RNA Pol III229,229, 
and, if left unchecked, can be detrimental to cellular processes108,111,123. In homeostatic 
conditions, Alu elements are processed by Dusp11 to remove the diphosphate group231, in 
essence inhibiting the cell’s ability to recognize these endogenous elements as viral. Recent 
studies have demonstrated that Dusp11 loss-of-function mutations lead to increased levels 
of Alu-derived REs in vitro232, and overexpression of Alu elements is a common hallmark 
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of neurodegenerative diseases111,233. In collaboration with the lab of Dr. Chris Sullivan at 
the University of Texas at Austin, we aim to determine if Dusp11 function in the murine 
RPE results in a similar AMD-type phenotype as that seen in Dicer1-deficient mice233–235. 
4.2: Results  
Dusp11Tm1a(EUCOMM)Wtsi mice (hereafter referred to as Dusp11) were previously 
generated by the International Mouse Phenotyping Consortium in the C57BL/6N mouse 
strain. This strain harbors a mutation within the Crb1 gene (rd8 allele) which causes a 
retinal degeneration phenotype236. To begin our studies using these mice, we first had to 
breed out the Crb1rd8 allele. Sperm from Dusp11Tm1a male mice were used to rederive the 
Dusp11Tm1a allele in wildtype C57BL/6J pseudo-pregnant females, generating pups 
heterozygous for Crb1rd8. We eliminated the Crb1rd8 allele within two subsequent 
generations however, the data reported in this chapter were generated using mice which 
contained both Crb1+/+ and Crb1+/rd8 alleles. 
Dusp11Tm1a mice harbor a promoter-less selection cassette that functions to create an 
mRNA splicing defect within the Dusp11 gene body and were reported to have smaller 
eyes than their wildtype counterparts237, but no analysis has validated those findings. This 
study aimed to characterize the Dusp11Tm1a/Tm1a phenotype, specifically within the retina 
and RPE. It is important to note that all results reported in this chapter are derived from an 
ongoing longitudinal study and will continue past the publication date of this document.  
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4.2.1 CHARACTERIZATION OF DUSP11TM1A/TM1A PHENOTYPE 
Dusp11Tm1a/Tm1a mice are viable, survive into adulthood, and are capable of producing 
offspring. Dusp11Tm1a/Tm1a mice have a noticeably shorter muzzle length compared to their 
siblings by the weanling stage (P21) which continues through adulthood (data not shown). 
Although some Dusp11Tm1a/Tm1a pups appear smaller at birth, they generally reach the same 
body size and weight as their siblings by P60 and do not vary from their siblings through 
P270 (Figure 4.1). The shortened muzzle and smaller eye phenotypes are apparent 
throughout adult life and are independent of sex (data not shown). After noting these 
general differences, we began assessing Dusp11 localization within the eye and 




Figure 4.1. Dusp11 function is not required to maintain body weight.  
Top: Weight in grams (g) of female mice from P60 to P270. Bottom: Weight of male mice 
from P60 to P360. Dusp11+/+ = Black circle; Dusp11+/Tm1a = Magenta square; 
Dusp11Tm1a/Tm1a = Blue diamond. n > 3 between P60 & P270; weights of P300+ mice are 
not yet quantifiable. 
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4.2.1: DUSP11TM1A/TM1A MICE DISPLAY RETINAL LAMINATION DEFECTS BY P210. 
Previous work demonstrated the requirement for Dicer-mediated miRNA processing 
within the retina, and Dicer loss-of-function mutants developed retinal lamination defects 
and the buildup of drusen deposits under the RPE108,235. These retinal abnormalities, 
commonly associated with AMD, began to emerge by approximately three months of 
age108,235. Since 3pRNAs require processing by Dusp11 in order for their association with 
Dicer and the AGO complex, we hypothesized that our Dusp11 mice would produce a 
similar AMD-like phenotype and age of onset.  
To determine the presence and/or age of onset of any retinal phenotype, we performed 
a longitudinal experiment using Spectral Domain Optical Coherence Tomography (SD-
OCT). 37 mice were used in this study (Dusp11+/+ n=9, Dusp11+/Tm1a n=17, 
Dusp11Tm1a/Tm1a n=11), and each mouse was imaged approximately every 30 days from 
P60-P360. Contrary to our hypothesis, no obvious retinal lamination defects were detected 
within the first six months of age (Figure 4.2 and 4.3). Beginning around P270 however, 
Dusp11Tm1a/Tm1a mice presented with lamination abnormalities (Figure 4.2C). In particular, 
the ONL appeared thinner, having a pinched-like appearance between the RPE and INL 
(arrow in Figure 4.2C) compared to the smooth lamination pattern seen in sibling controls 
(Figure 4.2B). To validate these findings, we used proprietary software developed by 
Bioptigen Inc. to automatically segment the SD-OCT images, measuring for retinal 
thickness (Figure 4.2) and lamination (Figure 4.3)238–241. All measurements obtained were 
analyzed for statistical significance using GraphPad Prism 8.0.  
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Total retinal thickness measurements remained constant between Dusp11Tm1a/Tm1a mice 
and controls through P150 (Figure 4.2D). By P180+, Dusp11Tm1a/Tm1a retinae began to show 
an overall reduction in thickness compared to their sibling controls (Figure 4.2D). Total 
retinal thickness was comparable between Dusp11Tm1a/Tm1a and sibling controls through 
P150 (Figure 4.3C). However, Dusp11Tm1a/Tm1a mice began to display an overall thinning 
of the retina starting at P180 (Figure 4.3C, p <0.05). To ascertain if these measurements 
were a result of overall retinal thinning or layer-specific changes, we compared 
measurements of the inner (RNFL, IPL, and INL), middle (OPL and ONL), and outer retina 
(IS/OS and RPE) across all time points. Strikingly, the inner and outer retinal thicknesses 
were consistent between sibling controls and Dusp11Tm1a/Tm1a mice across all time points 
(Figure 4.3E,G). In comparison, the middle retina is statistically thinner in the 
Dusp11Tm1a/Tm1a compared to controls from P180-P240 (Figure 4.3F). These measurements 
indicate a thinning of the ONL, which is a characteristic of AMD242. 
We then broke down these measurements into each of the retinal layers to determine 
whether the thinning within the middle retina is due to changes in the OPL, ONL, or both. 
Indeed, the proportion of the ONL within the Dusp11Tm1a/Tm1a shows a similar decreasing 
trend (Figure 4.3E) alongside the OPL reduction at P180 and P210 (Figure 4.3D). This 
reduction in OPL and ONL proportions correlates with increases of the RNFL (Figure 
4.3A) and IS (Figure 4.3F) layers of the retina. All other layers show no significant changes 
across all time points. The onset of these aberrations within the Dusp11Tm1a/Tm1a are 
possibly consistent with degenerative retinal diseases, however this model requires further 
analyses through SD-OCT, histology, and immunohistochemistry. 
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(Figure 4.2 continued on next page) 
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Figure 4.2. Dusp11Tm1a/Tm1a mice begin to display retinal thinning by P180.  
A. Diagram (left) and example OCT image (right) of the murine retina and the 
corresponding layers indicated in the center. Vertical lines depict measurements of the 
inner retina (cyan), middle retina (magenta), outer retina (green), and total retinal thickness 
(white). B. Dusp11+/Tm1a control with normal retinal lamination. C. Dusp11Tm1a/Tm1a 
showing retinal deformation within the middle retina domain (arrow). D. Average total 
retinal thickness over time of all samples measured. E-G. Average inner (E), middle (F), 
and outer (G) retinal thicknesses over time from P60-P240 (x-axis). Note: images in B,C 





(Figure 4.3 continued on next page) 
 66 
Figure 4.3. Dusp11Tm1a/Tm1a display quantifiable changes in retinal lamination by P210.  
A. Proportion of the RNFL layer of the total retinal thickness. B. Proportion of the IPL 
layer. C. Proportion of the INL layer. D. Proportion of the OPL layer. E. Proportion of the 
ONL layer. F. Proportion of the IS layer. G. Proportion of the OS layer. H. Proportion of 
the RPE layer. All data collected approximately every 30 days from P60-P240 (x-axis). n > 




















Results reported in this chapter lay the groundwork for future studies of Dusp11 
function within the retina. Although Dusp11 is not critical for normal development and 
viability of the mouse, its requirement within the retina is becoming apparent. Indeed, our 
results show that Dusp11 function is required to maintain retinal lamination in older mice 
(Figure 4.2 and 4.3). Of note, the lamination defects identified here (Figure 4.2 and 4.3) 
are suggestive of retinal degeneration, and the pinched-like deformity seen in Figure 4.2C 
is similar in pattern to reports of choroidal neovascularization235,243 though continued 
analyses through P360 will be necessary to verify these results. Interestingly, Dusp11+/Tm1a 
mice were occasionally found to have a more dramatic change in their retinal layer 
measurements than Dusp11Tm1a/Tm1a mice. Since the SD-OCT analysis was conducted using 
earlier generations after the rederivation mentioned previously, we suspect that the 
differences seen in heterozygous mice are indicative of mouse strain backgrounds 
variations.  
Despite these initial reports of Dusp11Tm1a/Tm1a retinal phenotypes, these defects arise 
at later time points than those seen in Dicer mutants235. It is important to note the Dusp11 
is only known to affect the processing of 3pRNAs, a small component of the miRNA 
pathway231, whereas Dicer is critical for much of the pre-miRNA processing244. These vast 
differences in miRNA governance is likely a reason for the delayed onset of an AMD-like 
phenotype in Dusp11Tm1a/Tm1a retinae (Figure 4.2 and 4.3) compared to controls. These 
 68 
results implicate Dusp11 as a potential regulator of retinal homeostasis and lends a unique 
view of neurodegenerative disease regulation. 
Localization of Dusp11 from previous reporting in vitro have identified Dusp11 within 
the nucleus and cytoplasm222,231, however, no evidence has been reported of Dusp11 
localization in vivo and if there are tissue-specific differences in its localization or function. 
We have begun characterizing Dusp11 localization in vivo through immunohistochemistry 
using a Dusp11 polyclonal antibody on RPE flat mounts (data not shown). Notably, we 
detected Dusp11+ puncta along the cellular membranes suggesting a potential role at cell-
to-cell junctions. These unexpected results have led us to hypothesize that Dusp11 may 
have tissue-specific localization and function. 
Accordingly, we collected various organs to determine if Dusp11 localization was 
tissue-dependent. Remarkably, we found Dusp11 localization was as varied as the tissues 
analyzed (data not shown). Of note, Dusp11 displayed 1) diffused localization throughout 
the cytoplasm and nuclei of the liver and corneal endothelium, 2) nuclear-specific 
localization within the corneal epithelium, 3) cytoplasmic localization within the heart, and 
4) restricted localization to cell-to-cell junctions within hair follicles of the skin. When 
considering Dusp11 localization within the liver and corneal endothelium, it is possible 
that this non-specific binding is due to tissue autofluorescence. It will be essential to 
compare these stain patterns between controls and Dusp11Tm1a/Tm1a tissues and to ensure 
minimal autofluorescence using established tissue-clearing protocols245,246. Although these 
results are promising and suggest the potential for cell type-specific localization or 
function, more in-depth analyses are required to determine Dusp11 function in vivo. 
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Nonetheless, these Dusp11+ puncta along epithelial cell membranes are thought-provoking 
and require experimental validation. 
Previous reports have identified the intercellular transfer of miRNAs through gap 
junctions (GJs)247,248; more recently demonstrating that these GJ-mediated miRNAs 
function to regulate gene expression within the neighboring cell249. Disruption of GJ-
mediated miRNA transfer within the developing cochlea was shown to result in a 
developmental hearing disorder in mice250. Additionally, gliomas have demonstrated the 
capacity to transfer miRNAs across GJs with astrocytes and ultimately affect the 
invasiveness of this aggressive disease251,252. Considering Dusp11’s ability to identify and 
modify 3pRNAs, one could hypothesize that RPE cells proactively stage this enzyme at 
cell-to-cell junctions with the purpose of identifying and processing viral-like RNAs as 
they travel between cells. Indeed, retroviruses like HIV are capable of coopting GJs for the 
transfer of viral particles between cells253. Therefore, positioning Dusp11 at GJs could act 
as an early warning system for the RPE, a highly sensitive and critical tissue for 
maintaining vision.  
Investigations into Dusp11 function have been limited and only recently shown to bind 
3pRNAs223,232. Its ability to bind RNA is unique among the Dusp family members231 and 
will challenge our views on how these enzymes function in vivo to modify gene expression 
and regulate retroviruses, and more specifically how Dusp11 functions in a tissue-
dependent fashion. Undoubtedly, evidence provided in this dissertation and future 
experiments will inspire novel ideas on how Dusp11 modulates gene expression, retroviral 
activity, and how this may contribute to the onset of AMD or other retinal degenerative 
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diseases. The results reported within this study, and those still ongoing, will provide unique 
insights into Dusp11’s function in vivo and trigger new ideas for studying the relationships 




































CHAPTER 5: FUTURE DIRECTIONS. 
 
5.1 Summary of work 
This dissertation focuses on epigenetic regulation during retinal development and 
disease, particularly through the DNA methylation and miRNA pathways. DNA 
methylation is a critical mechanism through which our cells regulate gene expression, 
cellular identity, and survival. miRNAs work in conjunction with DNA methylation to 
modulate these epigenetic signatures and promote cellular homeostasis and differentiation. 
In Chapter 2, I demonstrate a role for dnmt1 function in the maintenance of retinal stem 
cells (RSCs) within the zebrafish retina. Disruption of dnmt function resulted in depletion 
of the RSC population through disruption of the cell cycle, increased cell death, and 
overexpression of retroelements (REs) (Illustration 5.1). In Chapter 3, I generated and 
established combinatorial de novo dnmt mutants to assess their contribution to retinal 
development and differentiation. Although these mutants did not develop any obvious 
retinal abnormalities, further validation is required to parse out redundant versus allele-
specific defects. In Chapter 4, I conduct the first in vivo characterization of potential eye 
functions for the unique dual-specificity phosphatase enzyme, Dusp11, to determine its 
contribution to retinal development, differentiation, and disease. Although the evidence 
presented in Chapter 4 is preliminary, future analyses of this pathway will be critical for 
expanding our current understanding of the epigenetics field and Dusp11’s function in the 
retina. Furthermore, the mutant and transgenic alleles generated in this thesis will expand 
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the current repertoire of tools available for future investigations of retinal development and 
disease. 
5.2 Determining the contribution of maintenance DNA methylation to retinal 
stem cell homeostasis 
In Chapter 2, I presented evidence demonstrating a requirement for dnmt1 function in 
RSCs maintenance, without which RSCs are lost. Although the data provided clearly 
support this conclusion, the exact mechanism of RSC loss was not established. As 
discussed in Chapter 2.3, a likely mechanism of dnmt1-/- RSC loss occurs through a non-
p53-mediated cell death pathway. To determine which cell death pathway is regulated by 
maintenance DNA methylation and responsible for RSC loss, it will be necessary to 
continue these studies through gene expression studies and cell death pathway modulation. 
In Chapter 2.3, I hypothesized that pyroptosis and necroptosis are likely cell death 
pathways contributing to dnmt1-/- RSC loss. However, attempts to modify necroptotic 
processes via pharmacological manipulation were unsuccessful and genetic tools to assess 
this pathway within the zebrafish require further development. In contrast, tools for 
assessing the role of pyroptosis, an alternative mode of cell death, in zebrafish development 
and tissue function are available254. Previous reports demonstrate a role for autophagy, a 
common trait of the pyroptotic pathway, in the clearance of damaged cellular organelles 
and debris and has been shown to be independent of p53 function255,256. Defects within 
autophagy and lysosomal biogenesis pathways were also shown to result in 
neurodegenerative disease phenotypes257,258.  
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To address this possibility, I acquired both the Tg(CMV:EGFP-map1lc3b)zf155 and 
Tg(CMV:mCherry-map1lc3b)scf4 transgenic lines (kindly donated by Dr. Donghun Shin’s 
lab254 and mated them into the dnmt1s872 background. These transgenic lines provide in 
vivo detection and tracking of intracellular autophagic and lysosomal processes within the 
zebrafish254. A known repressor of autophagy is mTOR, a key effector of multiple cellular 
processes including cell growth, proliferation, and aging255. Biochemical inhibitors of the 
mTOR pathway, namely Rapamycin, have been shown increase cellular autophagy259,260. 
Additionally, 3-methyladenine (3-MA) inhibits autophagy in the zebrafish260. Thus, the use 
of the dnmt1;map1lc3b transgenic lines in combination with pharmacological 
manipulations, will elucidate any aberrant autophagic processes within dnmt1-/- RSCs and 
if this contributes to RSC loss via pyroptosis.  
In parallel, we are developing multiple experimental tools to determine the function of 
REs within dnmt1-/- RSCs. We aim to 1) identify and characterize the expression levels of 
RE families when hypomethylated, 2) modulate RE activity through pharmacological 
inhibition of retroviral transcription, 3) utilize macrophage/microglia-deficient zebrafish to 
determine the requirement for dnmt1-/- RSC clearance via the innate immune system, and 
4) to determine the contribution of RE transposition to DNA damage and chromosomal 
recombination. Results from these experiments will be crucial for narrowing in on the 
precise mechanism of RSC loss and potentially implicate these processes for the 




Illustration 5.1. Working model of dnmt1 function in RSCs.  
Left. Wildtype dnmt1 functions to maintain the methylome of proliferating cell. This limits 
RE expression such that retrotransposition is limited. Right. dnmt1-/- RSCs are unable to 
maintain the methylome, thus allowing for increased RE expression. Endogenous viral 
sensors within the cytoplasm detect these viral elements and initiate an immune response. 
Increased numbers of RE transcripts become translated within the cytosol, transported into 









5.3 Elucidating the function of de novo DNA methyltransferases  
Our original expectations that de novo dnmts would demonstrate pairwise functional 
redundancy was quickly challenged and determined to be incorrect. Indeed, the six dnmt3 
paralogs have suggested a more complex story which requires careful dissection. 
Experiments are currently underway to continue this project by first outcrossing these lines 
to ensure genetic diversity, thus limiting defects associated with inbreeding, and then 
attempting future incrosses to acquire a full panel of the six mutant dnmt3 paralogs. 
However, the possibility exists that loss of de novo dnmt function is not detrimental to 
zebrafish development and viability. Recent studies have shown that this is true in the case 
of the red flour beetle261262, and instead the over-expression of dnmt3 or dnmt3 gain-of-
function alleles lead to cellular or tissue impairment62,263. Future experiments to address 
this possibility would include generating transgenic zebrafish that harbor inducible 
constructs to over express the de novos singularly or in combination and either systemically 
or tissue-specifically. Such methods will include the Gal4/UAS system264–266, Tet-
ON/OFF267,268, or CRISPR/Cas9-activator and repressor constructs269,270.  
An alternate explanation for why the dnmt3 paralogs do not display overt phenotypes 
could be how they function in gonadal development. We know that dnmt3 family members 
function in genomic imprinting209,210,271, but the extent to their redundancy in this process 
is still unknown. Genomic imprinting is a process through which the established DNA 
methylome is passed down from parent to offspring, and disruption of these methylation 
patterns is known to have a detrimental impact on embryonic development63,272.  
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The potential for developmental defects, specifically in gonadal development, in these 
combinatorial dnmt3 mutants is high. DNA methylation, and more specifically its role in 
genomic imprinting, is known for its repression of REs during spermatogenesis191,192,273 
and oogenesis274,275. DNA hypomethylation within the developing gonads results in 
derepression of REs, which can cause a number of developmental defects arising from 
chromosomal breakages and recombinations276–278. Precise control of RE activity is 
achieved through the cooperation of both DNA methylation and Piwi-interacting RNA 
(piRNA) pathways279. The fact that we were unable to acquire offspring carrying all of the 
necessary dnmt3 mutant alleles suggests that this is a likely possibility. Future in-depth 
analyses of gonadal development within these combinatorial mutants will be essential for 
teasing apart the redundant and/or exclusive functions of the de novo dnmt3 family in 
regards to genomic imprinting and potentially guide further analysis to determine their 
retinal function. 
5.4 Determining Dusp11 function in retinal degenerative disease 
Studies of Dusp11 function are limited and primarily focus on its function in removing 
two phosphates from 3pRNAs, transcripts produced by RNA Pol III280. The data reported 
in Chapter 4 provides a novel, introductory glimpse into how this unique phosphatase 
potentially functions in vivo, and particularly within the retina. These results are 
preliminary and require further validation which is currently underway. In particular, these 
efforts are focused on identifying if Dusp11 loss-of-function phenocopies the AMD-like 
phenotype seen in Dicer-deficient retinas108,235. These analyses, first assessed through 
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longitudinal experiments using spectral domain optical coherence tomography (SD-OCT), 
of wildtype, heterozygous, and Dusp11Tm1a/Tm1a mice from P60-P360 demonstrate the 
emergence of retinal lamination defects (Figure 4.4 and 4.5) beginning around P180. The 
continuance of this longitudinal experiment will confirm if these defects arise solely within 
the Dusp11Tm1a/Tm1a retina if they result in retinal degeneration. Since we are collecting 
rectangular volume data via SD-OCT, we are able to take additional measurements of the 
sibling and Dusp11Tm1a/Tm1a retinal blood vessels. Should these results prove fruitful, then 
we also plan on assessing retinal blood flow in the Dusp11Tm1a/Tm1a retina and how that may 
contribute to a retinal degeneration phenotype. 
A more in-depth characterization of Dusp11’s intracellular function is underway and 
consists of histological and immunohistochemistry analyses to determine its expression 
pattern, localization, and retinal lamination defects. Functionality of these retinae will be 
tested through 1) electroretinography (ERG), a common methodology to assess 
photoreceptor function281 and/or 2) intense light to induce cellular stress upon the 
photoreceptors. This methodology is frequently used to evaluate how photoreceptor stress 
can lead to ocular defects. This experimental setup will determine if Dusp11 function is 
required for a cellular response to photoreceptor stress. Taken together, the evidence 
supplied in this dissertation underscores the importance of epigenetic mechanisms required 
for retinal cell homeostasis. Future works will be critical for our understanding of how 





Appendix A: dnmt Material and Methods 
A.1: ZEBRAFISH MAINTENANCE  
Zebrafish (Danio rerio) were maintained at 28.5°C on a 14 h light/ 10 h dark cycle. All 
protocols used within this study were approved by the Institutional Animal Care and Use 
Committee of The University of Pittsburgh School of Medicine, and conform to the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals. Mutant 
alleles used in this study were dnmt1s872 and tp53zdf1. dnmt1s872 and tp53zdf1 zebrafish were 
genotyped using BioRad’s CFX Manager 3.1 and Precision Melt Analysis software 
(v4.0.52.0602). All genotyping primers are listed in Table A1. Transgenic 
Tg(CMV:Has.L1RE3,EGFP,myl7:EGFP)pt701 zebrafish were generated as described265 
using constructs generously provided by Kristen Kwan and Chi-Bin Chien (University of 
Utah, Salt Lake City). 
A.2: BRDU LABELING 
To assess cellular proliferation, larvae were incubated in 10mM BrdU for either 2 or 
12 hours, after which the BrdU was washed out and larvae were either collected or used 





Table A.1. List of primer sequences and experimental purpose used in the dnmt1 study. 
Gene / 
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A.3: IMMUNOHISTOCHEMISTRY AND FLUORESCENT LABELING: 
Immunohistochemistry performed as described previously282. The following antibodies 
and dilutions were used: anti-BrdU antibody (Abcam, ab6326, 1:250), anti-phospho-
histone H3 (Ser10) (EMD Millipore, 06-570, 1:250), anti-GFP (Thermo Fisher Scientific, 
A-11122, 1:50), goat anti-rat Cy3 secondary (Jackson Immuno Research, 112-165-003, 
1:500), goat anti-rabbit Cy3 secondary (Jackson Immuno Research, 111-165-144, 1:500), 
and goat anti-rabbit Cy5 secondary (Jackson Immuno Research, 711-035-152, 1:500). 
Nuclei were counterstained with DAPI using Vectashield with DAPI (Vector Laboratories, 
H-1200). F-actin was labeled using AlexaFluor 633 Phalloidin (Thermo Fisher Scientific, 
1:33, A22284). TUNEL-labeling was accomplished using TMR-Red In situ Cell Death 
Detection Kit (Sigma Aldrich, 12156792910).  
A.4: CLONING AND PROBE SYNTHESIS  
CMZ-specific probes have been published previously120,133. Retroelement probes were 
generated using reverse transcription-polymerase chain reaction (RT-PCR) on Trizol-
isolated RNA from 24hpf and 5dpf embryos. Primer sequences were kindly provided by 
Dr. Kirsten Sadler (NYU Abu Dhabi), and PCR products were ligated into pGEM-T-easy 
vector (Promega Cat# PR-A1360) and verified by Sanger sequencing. Plasmids were 
linearized and used as templates to transcribe digoxigenin-labeled RNA probes in vitro 
(Roche).  
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A.5: IN SITU HYBRIDIZATION  
Hybridizations using digoxigenin labeled antisense RNA probes were performed 
essentially as described283, except that they were pre-incubated with 1 mg/mL Collagenase 
type 1A (Sigma, C9891) to allow probe diffusion throughout the tissue. All probe primer 
sequences and plasmid construct information are listed in Table __. 
A.6: MICROSCOPY AND IMAGE PROCESSING  
For sectioned embryos, imaging was performed with an Olympus FV1200 confocal 
microscope. Confocal Z-stacks were collected in 1µm optical sections. Z-stacks were max-
projected using ImageJ (version 1.52r) software (National Institutes of Health) and 
quantification was conducted using the “Cell Counter” plugin. Figures were prepared using 
Adobe Illustrator CS6 (Adobe Systems). In situ cryosections were imaged utilizing a Leica 
DM2500 with a 100X oil immersion objective (NA: 1.25).  
A.7: CELL COUNTING AND QUANTIFICATION: 
Each data point collected from an individual larva. Each larva was analyzed using three 
consecutive 12 µm sections of the central retina using the optic nerve and lens morphology 
as retinal landmarks. The average of the three consecutive sections was used as a single 
data point (n >4 for all datasets). Proportions of retinal domains were calculated by dividing 
the number of DAPI-labeled nuclei in each domain over the total number of retinal nuclei.  
 82 
A.8: STATISTICS  
For all statistical analysis, data were imported into GraphPad Prism 8 software. 
Quantification of nuclei and immunolabeled cells was statistically assessed using Student’s 
two-tailed unpaired T-test with p <0.05 as a significance threshold.  
A.9: GENERATION OF TG(CMV:HSA.L1RE3,EGFP,MYL7:EGFP)PT701: 
pLRE-mEGFPI plasmid was generously donated by Dr. John V. Moran (The 
University of Michigan School of Medicine)173. The Hsa.L1RE3-EGFP sequence was 
isolated from the pCEP4 backbone using NotI and SalI restriction enzymes and then 
inserted into pME-MCS plasmid from the Tol2 Gateway Kit. LR Clonase II Plus was used 
to carry out all Multisite Gateway assembly reactions265 using p5E-MCS (19ng), pME-
Hsa.L1RE3-EGFP (77ng), p3E-polyA (19ng), and pDestTol2CG2 (103ng) plasmids. 
Capped Tol2 mRNA was synthesized from pCS2FA-transposase using the Ambion 
mMessage mMachine Sp6 in vitro transcription kit (Thermo Fisher Scientific, AM1340). 
Tol2 mRNA (75pg) was co-injected with pDEST- Hsa.L1RE3-EGFP (40 pg) into 
dnmt1+/-;p53+/- incross embryos at the 1-cell stage. Embryos displaying acceptable levels 
of mosaic myl7:EGFP expression were raised to adulthood, and outcrossed to screen for 
founders. F1 embryos displaying ubiquitous myl7:EGFP expression were isolated and 
reared to generate the stable line Tg(CMV:Hsa.L1RE3,EGFP,myl7:EGFP)pt701.  
A.10: TALEN- AND CRISPR/CAS9-MEDIATED MUTAGENESIS 
TALEN sites were chosen based on sequence specificity and ease of genotyping via 
RFLP according to previous protocol284. TALEN constructs were assembled using the 
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Golden Gate platform202,285 and injected into 1-cell stage embryos. Germline transmission 
was determined through sperm collection, PCR, RFLP, and Sanger sequencing to identify 
indels that was predicted to result in a non-functional protein product.  
All mutant alleles generated using CRISPR/Cas9 mutagenesis were created following 
the protocol as described previously204, and mutant alleles were validated as stated above 
for the TALEN generated alleles. Genotyping of all mutant alleles was conducted via 
RFLP or HRM analysis and larvae were processed for retinal phenotype analyses. All de 















Table A.2. List of primer sequences used in the de novo dnmt study. 
Gene 
target(s) 
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Appendix B: Dusp11 Material and Methods 
B.1: MOUSE COLONY MAINTENANCE 
Healthy adult male mice from the transgenic line Dusp11Tm1a(EUCOMM)Wtsi were donated 
by Dr. Chris Sullivan’s lab (University of Texas at Austin) and used for rederivation in 
C57BL/6J pseudo pregnant female mice at the Magee Women’s Research Center, 
Pittsburgh, PA. Mice were maintained in the University of Pittsburgh Animal Facility in a 
12-hour light/dark cycle and had free access to water and standard laboratory feed in 
accordance with the Institutional Animal Care and Use Committee. Mice were genotyped 
using the PCR protocol defined by the International Mouse Phenotyping Consortium 
(IMPC). Genotyping primers can be found in Table B1. The Dusp11Tm1a allele was 
generated at IMPC in the C57BL/6N mouse strain, which retains a known mutation (rd8 
allele) in the Crb1 gene. Crb1rd8/rd8 mice display retinal degenerative phenotypes, thus this 
mutation has been bred out to the C57BL/6J mouse strain for the past 3 generations.  
B.2: SPECTRAL DOMAIN - OPTICAL COHERENCE TOMOGRAPHY  
Spectral-domain optical coherence tomography (SD-OCT) scanning was adapted from 
the procedures described previously286. Before each session, mice were anesthetized with 
an intraperitoneal injection of ketamine and xylazine to prevent large movements during 
SD-OCT image acquisition. Mice were secured on a stage that allowed for free rotation to 
acquire images focusing on the retina. All images were acquired using SD-OCT 
(Bioptigen, Inc., Research Triangle Park, NC). All SD-OCT images were taken as 
rectangular volumes of 0.8 (W) x 0.8 (L) x 1.64 (H) mm and consisted of a 1000 A-scans 
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per B-scan, 200 B-scan frames, and 1024 samplings/A-scan in depth with an average of 
three volumes. SD-OCT images were then processed using the mouse automated 
segmentation function on the Bioptigen Diver 3.0 software to acquire retinal thickness 
measurements. Retinal lamination defects were detected using ImageJ287, version 1.50e. 
SD-OCT files were loaded using the OCT Reader plugin, cropped, and sub-stacked around 
target location. Breathing and motion artifacts were processed using the StackReg plugin 
to create confluent frames which were then max-projected to create the final images. All 
data analyzed using SD-OCT were conducted on the second generation of Dusp11Tm1a mice 
bred into the C57BL/6J mouse strain.  
B.3: STATISTICAL ANALYSIS 
All data collected for mouse weights and retinal thickness were imported into 
GraphPad Prism 8 software and analyzed for statistical significance using two-way 
ANOVA with Tukey’s post hoc analysis using p <0.05 as a significance threshold. Error 
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